Xenetic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.

About XBIO

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. 

CEO
Jeffrey F. Eisenberg
CEOJeffrey F. Eisenberg
Employees
4
Employees4
Headquarters
Framingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded
2011
Founded2011
Employees
4
Employees4

XBIO Key Statistics

Market cap
6.01M
Market cap6.01M
Price-Earnings ratio
-1.47
Price-Earnings ratio-1.47
Dividend yield
Dividend yield
Average volume
6.65K
Average volume6.65K
High today
$3.90
High today$3.90
Low today
$3.90
Low today$3.90
Open price
$3.90
Open price$3.90
Volume
1.35K
Volume1.35K
52 Week high
$5.97
52 Week high$5.97
52 Week low
$2.55
52 Week low$2.55

XBIO News

TipRanks 5d
Xenetic Biosciences, Inc. Under Pressure: Shareholder Activism Threatens Stability and Financial Future - TipRanks.com - TipRanks

Xenetic Biosciences, Inc. (XBIO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Xenetic Biosciences, Inc. faces financial risks fr...

Yahoo Finance 6d
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results - Yahoo Finance

Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or met...

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.